XRD & XRF in the Pharmaceutical Industry

The development of drugs in the pharmaceutical industry is a long-term process. It can often take a number of years from the start of the research project, to when a drug is finally available on the market. Substance quality and its specifications are based on substance analysis. That knowledge is later used for quality control of the pharmaceutical substance during full-scale production. Product analysis involves dealing with the various formulations used for toxicological studies, clinical studies, and marketing. The results from such work lead to specifications that form the basis for the QC of the product.

For both substances and formulations there is an increasing interest in the introduction of process analytical chemistry.There is growing interest in how to apply XRD & XRF in the Pharmaceutical Industry. Both benchtop XRD and XRF are being used by a number of large and start-up pharmaceutical companies to assist them with their research, and help them achieve their next breakthrough medicines. Bruker D2 PHASER Benchtop XRD enables powder diffraction and structural analysis. Bruker S2 PUMA Benchtop EDXRF enables viable and efficient material identification and quantification of elements present.